%0 Journal Article %1 atschekzei2023rituximab %A Atschekzei, F %A Fedchenko, M %A Elsayed, A %A Dubrowinskaja, N %A Graalmann, T %A Ringshausen, F C %A Witte, T %A Sogkas, G %D 2023 %J RMD Open %K kalinke %N 4 %R 10.1136/rmdopen-2023-003507 %T Rituximab to treat prolidase deficiency due to a novel pathogenic copy number variation in PEPD %U https://pubmed.ncbi.nlm.nih.gov/38088248/ %V 9

@article{atschekzei2023rituximab, added-at = {2024-01-04T16:38:34.000+0100}, author = {Atschekzei, F and Fedchenko, M and Elsayed, A and Dubrowinskaja, N and Graalmann, T and Ringshausen, F C and Witte, T and Sogkas, G}, biburl = {https://www.bibsonomy.org/bibtex/2d87be3999157a189be159a171ff03481/kalinke}, doi = {10.1136/rmdopen-2023-003507}, interhash = {0007e06b6db42929f8ad284647a9b4f7}, intrahash = {d87be3999157a189be159a171ff03481}, journal = {RMD Open}, keywords = {kalinke}, number = 4, timestamp = {2024-01-04T16:38:34.000+0100}, title = {Rituximab to treat prolidase deficiency due to a novel pathogenic copy number variation in PEPD}, url = {https://pubmed.ncbi.nlm.nih.gov/38088248/}, volume = 9, year = 2023 }